Sellas reports initial data on galinpepimut-S with checkpoint inhibitors for ovarian cancer and MPM Dec. 22, 2020
BioCryst reports encouraging phase I data on BCX-9250 for fibrodysplasia ossificans progressiva Dec. 22, 2020
HX-008 plus chemotherapy demonstrates promising safety and efficacy in first-line mTNBC Dec. 22, 2020
Menin/KMT2A inhibitor KO-539 shows encouraging preliminary results for treating R/R AML Dec. 22, 2020
RSS